BlackRock Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$190K Sell
3,318
-23,652
-88% -$2.17M ﹤0.01% 2667
2016
Q3
$3.45M Buy
26,970
+1,055
+4% +$135K ﹤0.01% 1288
2016
Q2
$3.23M Buy
25,915
+2,416
+10% +$278K ﹤0.01% 1282
2016
Q1
$1.97M Sell
23,499
-2,234
-9% -$184K ﹤0.01% 1557
2015
Q4
$2.55M Buy
25,733
+23,963
+1,354% +$2.57M ﹤0.01% 1361
2015
Q3
$217K Buy
1,770
+372
+27% +$50.5K ﹤0.01% 2511
2015
Q2
$214K Buy
1,398
+1,096
+363% +$181K ﹤0.01% 2560
2015
Q1
$52K Hold
302
﹤0.01% 2764
2014
Q4
$46K Hold
302
﹤0.01% 2787
2014
Q3
$32K Hold
302
﹤0.01% 2733
2014
Q2
$46K Hold
302
﹤0.01% 2705
2014
Q1
$39K Hold
302
﹤0.01% 2672
2013
Q4
$53K Buy
+302
New +$51.9K ﹤0.01% 2543

Other funds holding ELGX

BlackRock Group's ELGX Position: Q4 2016 in Review

BlackRock Group reduced its Endologix Inc (ELGX) stake by 88% in Q4 2016, selling an estimated $2.17M and leaving 3,318 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

BlackRock Group first reported a position in ELGX in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.45M in Q3 2016. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • BlackRock Group held 3,318 shares of Endologix Inc worth $190K as of Q4 2016.
  • BlackRock Group sold 23,652 Endologix Inc shares in Q4 2016, an estimated $2.17M.
  • Endologix Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2667 holding.
  • BlackRock Group first reported a position in Endologix Inc in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Group's Endologix Inc position peaked at $3.45M in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.